Cite
APA Citation
Catlett, I. M., Aras, U., Hansen, L., Liu, Y., Bei, D., Girgis, I. G., & Murthy, B. (2023). first‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2. Clinical and translational science, 16(1), 151–164. http://access.bl.uk/ark:/81055/vdc_100173979334.0x000015